Fine needle aspiration (FNA) can provide a timelier evaluation of neck masses than open biopsy, thus saving time, money and potentially improving health outcomes with earlier diagnosis and treatment. Fine needle aspiration for head and neck masses Masses felt by the clinician or detected with imaging scans often require further testing. Options for obtaining tissue…
Norton Cancer Institute is the only site in Louisville offering lutetium Lu 177 dotatate (Lutathera), a second-line treatment targeting advanced-stage neuroendocrine tumors in adult patients. The drug is indicated when a patient starts to lose response to the first-line therapies, lanreotide (Somatuline) and octreotide acetate (Sandostatin). Norton Cancer Institute To refer a patient to Norton…
The prognosis for gastric cancer is closely tied to the stage of the diagnosis. When found early, gastric cancer has a better survival rate. “Given the difference early diagnosis can make, it’s important that clinicians are aware of the red flags for gastric cancer,” said Jaspreet S. Grewal, M.D., Ph.D., a gastrointestinal oncologist at Norton…
Paul A. Tennant, M.D., has joined Norton Cancer Institute as a head and neck surgical oncologist. He treats complex benign and malignant conditions of the head and neck. Dr. Tennant sees patients at Norton Cancer Institute – Downtown. Norton Cancer Institute Head & Neck Tumor Program To refer a patient, visit Norton EpicLink and open…
A new regimen of FMS-related tyrosine kinase 3 (FLT3) inhibitor gilteritinib and venetoclax was tolerable at standard doses and produced high response rates for advanced, FLT3-mutated acute myeloid leukemia (AML) in a multicenter Phase 1 study. “The results were encouraging. We saw high rates of marrow response and promising overall survival for this high-risk group…
Accurate imaging is a crucial component of prostate cancer management for a number of reasons, including tumor localization, disease staging and detecting recurrence. Prostate-specific membrane antigen positron emission tomography (PSMA PET) scans offer an imaging approach that has the ability to detect recurrence earlier and enable clinicians to implement tailored treatment sooner. “PSMA imaging offers…
Sable C. Iglesias, DNP, APRN, CPHON, has joined Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, as a certified pediatric hematology/oncology nurse. A Louisville native, Sable graduated from University of Louisville with two degrees: a Bachelor of Science in nursing and a doctorate in nursing practice. Sable is a nurse practitioner and advanced practice…
Each year, as we look back over our progress and program highlights, we are struck by a singular fact. Time and again, what we are able to achieve is the result of exceptional teamwork. Our dedicated and innovative medical and radiation oncologists are specialists in their fields who work alongside others with expertise in cancer…
At Norton Cancer Institute, we are committed to giving our patients the opportunity to receive state-of-the-art, cutting-edge therapies. This is made possible because of the long-standing support of clinical trials by Norton Healthcare’s leadership and board of trustees. I specialize in blood cancers. Currently we have nearly 50 ongoing trials available to patients with multiple…
Ovarian cancer is personal to me. Two of my mom’s sisters died of the disease. One of the major issues with successfully treating ovarian cancer is how late it is typically diagnosed: stage IIIC. At that point, the cancer has spread throughout the abdominal cavity, and there are distant metastases throughout the omentum. Standard treatment…
Justin W. Gorski, M.D., Ph.D., has joined Norton Cancer Institute, specializing in treating cancers of the female reproductive system, including ovarian, uterine and cervical cancers. Dr. Gorski is a board-certified gynecologic oncologist. He received his medical training at the Drexel University College of Medicine in Philadelphia and completed his residency at the Icahn School of Medicine…
Our goal is to offer every patient the option of the latest treatment available for their cancer. To do that, Norton Cancer Institute is participating in approximately 170 clinical trials at any time. These clinical trials involve nearly 500 patients either enrolled and receiving treatment, or in follow-up. For the participating patients, these studies offer…